Very positive. Another potentially profitable application.
Step aside Cochlear. Here comes UCM.
This has all the earmarks to be a real winner.
Good Management. Highly marketing focused. Cash in the bank. Exceptional product. Strong investor support as many shareholder groups are within the medical professions (ie people who understand).
Do your own research and happy investing.
- Forums
- ASX - By Stock
- UCM
- another positive annoucement
another positive annoucement, page-2
Featured News
Add UCM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.005M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 23333 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23333 | 0.012 |
2 | 271818 | 0.011 |
2 | 400099 | 0.010 |
2 | 600000 | 0.009 |
1 | 120000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 50000 | 1 |
0.022 | 36903 | 1 |
0.030 | 22000 | 1 |
0.035 | 10083 | 1 |
0.100 | 57758 | 1 |
Last trade - 16.12pm 10/10/2024 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online